Overview
Roham Zamanian is a Pulmonary Medicine provider in Stanford, California. Dr. Zamanian is rated as an Experienced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Systemic Sclerosis (SSc), Cerebral Hypoxia, and Lung Transplant.
His clinical research consists of co-authoring 153 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Chronic Obstructive Pulmonary Disease (COPD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Pasteur Dr, Stanford, CA 94305
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Stephen Lazarus is a Pulmonary Medicine provider in San Francisco, California. Dr. Lazarus is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, Lung Metastases, and Asthma.
Samir Vora is a Pulmonary Medicine provider in Fremont, California. Dr. Vora has been practicing medicine for over 47 years and is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Atypical Pneumonia, Hospital-Acquired Pneumonia, and Advanced Bronchoscopy.
Luu Medical Group
Michael Luu is a Pulmonary Medicine provider in Vallejo, California. Dr. Luu is rated as a Distinguished provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Hospital-Acquired Pneumonia, Atypical Pneumonia, and Advanced Bronchoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pulmonary HypertensionDr. Zamanian isElite. Learn about Pulmonary Hypertension.
- Distinguished
- Pulmonary Veno-Occlusive DiseaseDr. Zamanian isDistinguished. Learn about Pulmonary Veno-Occlusive Disease.
- Systemic Sclerosis (SSc)Dr. Zamanian isDistinguished. Learn about Systemic Sclerosis (SSc).
- Advanced
- Cerebral HypoxiaDr. Zamanian isAdvanced. Learn about Cerebral Hypoxia.
- Lung TransplantDr. Zamanian isAdvanced. Learn about Lung Transplant.
- Experienced
- Acute Interstitial PneumoniaDr. Zamanian isExperienced. Learn about Acute Interstitial Pneumonia.
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Dr. Zamanian isExperienced. Learn about COVID-19.
- Heart Failure with Preserved Ejection Fraction (HFpEF)
- Idiopathic Dilatation of the Pulmonary Artery
- Interstitial Lung DiseaseDr. Zamanian isExperienced. Learn about Interstitial Lung Disease.